Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3728027 | 0.79 | GABRR1 (0.31) | GABRR1LMNA | |
| SCHEMBL19494859 | 0.79 | ALDH1A1 (0.40) | ALDH1A1TDP1 | |
| SCHEMBL1119824 | 0.79 | LMNA (0.46) | ALDH1A1TDP1CYP1A2GABRR1LMNA | |
| SCHEMBL3243167 | 0.77 | ALDH1A1 (0.39) | ALDH1A1TDP1 | |
| SCHEMBL13192615 | 0.77 | CYP1A2 (0.30) | CYP1A2GABRR1LMNA | |
| SCHEMBL27959803 | 0.77 | — | — | |
| SCHEMBL18930093 | 0.77 | MGAM (0.38) | LMNA | |
| SCHEMBL18930173 | 0.74 | CYP1A2 (0.41) | ALDH1A1TDP1CYP1A2LMNA | |
| SCHEMBL1507280 | 0.73 | — | — | |
| SCHEMBL1919646 | 0.73 | CA1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108883046-A | Personal care composition and the method for using such composition | 罗地亚经营管理公司 | 2018-11-23 | — | — | CN | disclosed |
| US-20020137642-A1 | Composition comprising a volatile fluoro compound and a process for removing make-up from the skin or cleansing the skin | L'OREAL, S.A. | 2002-09-26 | — | — | US | disclosed |
| US-6383998-B1 | CLEANSER FOR SKIN | L'ORÉAL (FR) | 2002-05-07 | — | — | US | disclosed |
| EP-1064929-A1 | Use of volatile fluorinated oil for attenuating skin deficiencies and for giving a matt skin appearance | L'OREAL (FR) | 2001-01-03 | — | — | EP | disclosed |
| EP-1064928-A1 | Use of at least one volatile fluorocompound in a make-up removing or cleansing composition | L'OREAL (FR) | 2001-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020137642-A1 | Composition comprising a volatile fluoro compound and a process for removing make-up from the skin or cleansing the skin | CUTA, FTO, FMNL1 | ALDH1A1 311/4885TDP1 55/4885CYP1A2 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.